The expressing signification of estrogen receptorβ in breast cancer

HAN Jing,WANG Pei-Jun,TANG Ru-Yong,FANG Jian-Ping
DOI: https://doi.org/10.3781/j.issn.1000-7431.2006.03.012
2006-01-01
Tumor
Abstract:Objective:To study the relationship between the expression of estrogen receptor β(ERβ) and the clinical pathological characteristics in breast cancer.Methods:Expression of ERβ was detected in 155 patients with breast carcinomas by immunohistochemistry.Results:The overall positive rate of ERβ was 42.6%(66/155).There was no statistically significant difference between the positive expression of ERβ in premenopausal and postmenopausal(P>0.05),and the expression of ERβ was also not correlated with lymph nodal metastasis(P>0.05)and distant metastasis(P>0.05).But the positive rate was correlated significantly with different tumor diameter(P<0.001) and pathologic staging(P<0.01).There was statistically significant difference between the positive expression of ERβ in infiltrating ductal carcinoma and ductal carcinoma in situ(DCIS)/ DCIS associated with small invasive foci(P<0.05),but there was no statistically significant difference between the positive expression of ERβ in infiltrating ductal carcinoma,mucinous carcinoma and invasive lobular carcinoma(P>0.05),there was also no statistically significant difference between the positive expression ERβ in mucinous carcinoma,invasive lobular carcinoma and DCIS/ DCIS associated with small invasive foci(P>0.05),and there was also no statistically significant difference between the positive expression of ERβ in mucinous carcinoma and DCIS/ DCIS associated with small invasive foci(P>0.05).Conclusion:Over-expression of ERβ is correlated with the occurrence,development and prognosis of breast cancer,it may be an important index of breast cancer.
What problem does this paper attempt to address?